Compound Summary


cyclosporin A
  Compound Information
 cyclosporin A

Compound Name:

cyclosporin A

Compound CID:

5284373

Synonyms:

cyclosporin A

cyclosporine

Ciclosporin

59865-13-3

Cyclosporine A

More...

Iupac Name:

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

InChI:

InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1

InChIKey:

PMATZTZNYRCHOR-CGLBZJNRSA-N

Canonical Smiles:

CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C

Isomeric Smiles:

CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C

Molecular Weight:

1202.6

Molecular Formula:

C62H111N11O12

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 cyclosporin A

Molecular Weight:

1202.6

Molecular Formula:

C62H111N11O12

Hydrogen Bond Donor Count:

5

Hydrogen Bond Acceptor Count:

12

Rotatable Bond Count:

15

Heavy Atom Count:

85

Complexity:

2330

  Synonyms
 cyclosporin A

cyclosporin A cyclosporin A

cyclosporin A

cyclosporine

Ciclosporin

59865-13-3

Cyclosporine A

Sandimmune

Sandimmun

Neoral

Cyclosporin

Ciclosporine

Gengraf

Ramihyphin A

Sandimmun Neoral

Sang-35

Ciclosporina

Ciclosporinum

Consupren

Equoral

Neoplanta

UNII-83HN0GTJ6D

Antibiotic S 7481F1

SangCyA

MFCD00274558

83HN0GTJ6D

MLS001333756

CHEBI:4031

CSA

S-Neoral

Cipol N

Sigmasporin Microoral

Cyclosporin A solution

DSSTox_CID_365

Ciclosporin (Ciclosporin A)

DSSTox_RID_75541

DSSTox_GSID_20365

SDZ-OXL 400

Ciclosporin A

OL 27-400

Abrammune

Imusporin

Optimmune

Seciera

Vekacia

Papilock Mini

Arpimune ME

Zinograf ME

Sandimmune Neoral

Ciclosporina Germed

(R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)

CYA

SMR000058578

Cicloral (antibiotic)

Debio088

Sang 35

Cyclosporine USAN:USP

Ciclosporine INN-French

Ciclosporinum INN-Latin

Ciclosporina INN-Spanish

Cyclospori

Sigmasporin

Cyclokat

Mitogard

Papilock

Pulminiq

Zyclorin

CicloMulsion

Ciclosporin;

CCRIS 1590

Ciclosporin DT

Consupren S

NSC290193

Modusik-A

HSDB 6881

NeuroSTAT

1cyn

2wfj

4jjm

NSC-290193

Cipol-N

NCGC00016890-01

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19

(R-R*,R*-(E))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)

Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl)

Cyclo(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl

DRG-0275

Prestwick_731

Ciclosporin INN

CAS-59865-13-3

NSC 290193

CsA & IFN.alpha.

1c5f

2z6w

S 7481F1

Cyclosporine manufacturer

Prestwick2_000435

Prestwick3_000435

CHEMBL160

Sang-2000

SCHEMBL3491

SCHEMBL4442

Nova-22007

Ikervis (opthalmic solution)

BSPBio_000450

Cyclosporin A & IFN.alpha.

MLS000028376

MLS002153454

MLS002207033

Verkazia (opthalmic solution)

SDZ-OXL-400

BPBio1_000496

GTPL1024

ANTIBIOTIC S-7481F1

DTXSID0020365

CHEBI:92233

AOB2581

ATH-002

OLO-400

CB-01-09 MMX

HMS1569G12

HMS2089A09

HMS2096G12

HMS2230M14

HMS3713G12

1,11-cycloL-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine

30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone

30-ethyl-33-(4E)-1-hydroxy-2-methylhex-4-en-1-yl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

30-ethyl-33-(4E)-1-hydroxy-2-methylhex-4-en-1-yl-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)

Cyclosporin A, Ready Made Solution

EX-A4110

HY-B0579

Tox21_110667

Tox21_301849

BDBM50022815

DE-076

ST-603

Cyclosporin A, >=98.5% (TLC)

AKOS015969287

Tox21_110667_1

CCG-208184

DB00091

EBD2126862

KS-1257

SDCCGSBI-0050230.P004

NCGC00093704-12

NCGC00164258-01

NCGC00164258-02

NCGC00164258-03

NCGC00255232-01

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

AT-12519

BC164336

C042

Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)

OL-27400

SBI-0050230.P003

AB0090560

OL-27-400

5946-EP0930075A1

5946-EP2289877A1

5946-EP2292601A1

5946-EP2292602A1

5946-EP2292603A1

5946-EP2292604A2

5946-EP2292618A1

5946-EP2293650A1

5946-EP2298737A1

5946-EP2298739A1

5946-EP2298740A1

5946-EP2298741A1

5946-EP2298771A2

5946-EP2301920A1

5946-EP2301940A1

5946-EP2308843A1

5946-EP2308861A1

J10181

J90049

M01532

865C133

A832514

Cyclosporin A, VETRANAL(TM), analytical standard

Q367700

SR-01000780563

Q-200913

SR-01000780563-3

BRD-K03222093-001-01-8

BRD-K13533483-001-03-0

Ciclosporin, European Pharmacopoeia (EP) Reference Standard

Cyclosporin A, from Tolypocladium inflatum, >=95% (HPLC), solid

Cyclosporine, United States Pharmacopeia (USP) Reference Standard

Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard

Cyclosporin A, from Tolypocladium inflatum, BioReagent, for molecular biology, >=95%

Cyclosporine, Pharmaceutical Secondary Standard; Certified Reference Material

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-(E,1R,2R)-1-hydroxy-2-methyl-pent-3-enyl-3,6,9,18,24-pentaisobutyl-21-isopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32

104250-72-8

30-Ethyl-33-((E)-1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone

  Experimental Data
 cyclosporin A

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 88.000000000000000 umol/L 18.000000000000000 S N2 24134630 Active
Caenorhabditis elegans 33.000000000000000 umol/L 18.000000000000000 S N2 33683565 Active
  Experimental Data Visualization
 cyclosporin A

  Statistics Data
 cyclosporin A

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans 18.000000000000000 2 2
  Statistics Data Visualization
 cyclosporin A